Posted on 9/16/20
Blue Cross Blue Shield of Massachusetts Honored with Two Stevie International Business Awards for Health News Service
Blue Cross Blue Shield of Massachusetts, Inc. has received two Stevie International Business Awards for the company's health news service, Coverage, in recognition of the valuable . . .
Posted on 9/16/20
Oxford Finance Closes $15 Million Credit Facility with Vedanta Biosciences
Oxford Finance LLC, a specialty finance firm that provides senior debt to life sciences and healthcare services companies worldwide, has announced the closing of a $15 . . .
Posted on 9/16/20
Takeda Opens New Cell Therapy Research and Development Facility
OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) kündigte heute die Erweiterung seiner Produktionskapazitäten für Zelltherapie durch die Eröffnung einer neuen 2.230 Quadratmeter großen Fertigungsanlage zur Forschung . . .
Posted on 9/16/20
Is Biogen Stock a Buy?
Biogen (NASDAQ:BIIB) hasn't had the best year -- and not necessarily because of the COVID-19 pandemic. Back in June, a judge invalidated a patent on Tecfidera, . . .
Posted on 9/15/20
Compass Therapeutics Provides Corporate Update
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Compass Therapeutics, Inc., a clinical-stage biotechnology company developing proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological . . .
Posted on 9/15/20
GreenLight Biosciences Receives $3.3 Million Grant to Develop Sickle Cell Disease Cure Using mRNA Gene Therapy
GreenLight Biosciences has received a $3.3 million grant from the Bill & Melinda Gates Foundation to develop new mRNA-based gene therapies for Sickle Cell Disease and . . .
Posted on 9/15/20
Hologic Prices Offering of $950 Million Senior Notes
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) announced today that it has priced its previously announced private offering of $950 million aggregate principal amount of 3.250% senior . . .
Posted on 9/14/20
Voluntis Obtains €2 Million in Non-dilutive Financing
CAMBRIDGE, Mass. & PARIS--(BUSINESS WIRE)--Voluntis (Euronext Paris, Ticker: VTX - ISIN: FR0004183960), a leader in digital therapeutics, announces today that it has obtained a state-guaranteed loan . . .
Posted on 9/14/20
Thermo Fisher Scientific Collaborates with AstraZeneca and University of Nebraska Medical Center
Thermo Fisher Scientific, the world leader in serving science, today announced new collaborations of the Thermo Fisher Precision Medicine Science Center (PMSC) with AstraZeneca and the . . .
Posted on 9/14/20
HiFiBiO Therapeutics Partnership With ABL Bio
CAMBRIDGE, Mass. & PARIS & SHANGHAI & HONG KONG--(BUSINESS WIRE)--HiFiBiO Therapeutics, a clinical-stage multinational biotherapeutics company focused on the development of novel antibodies in immunomodulation, today . . .
Posted on 9/14/20
Talaris Therapeutics Collaborates With Kentucky Organ Donor Affiliates
BOSTON & LOUISVILLE, Ky.--(BUSINESS WIRE)--Talaris Therapeutics, Inc., a privately held biotechnology company developing transformative cell therapies that have the potential to induce durable immune tolerance across . . .
Posted on 9/14/20
KalVista Pharmaceuticals Reports First Fiscal Quarter Results
CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease . . .
Posted on 9/14/20
2020’s States that Vaccinate the Most – WalletHub Study
With multiple companies racing to develop an effective COVID-19 vaccine but 1 in 3 Americans saying they wouldn’t get vaccinated, the personal-finance website WalletHub today released . . .
Posted on 9/14/20
Jounce Therapeutics: An Undervalued Biotech Flush With Big Pharma Cash
SummaryJounce therapeutics is a differentiated player in the hot immuno-oncology sector.JNCE stock has not been fairly priced after its newly struck partnership with Gilead Sciences, making . . .
Posted on 9/14/20
IPO Update: Dyne Therapeutics Readies $175 Million IPO
SummaryDyne Therapeutics had filed proposed terms for a $175 million U.S. IPO.The firm is advancing treatments for various muscle diseases.DYN has yet to enter Phase 1 . . .
Posted on 9/14/20
Moderna Slowed Enrollment in Its Phase 3 Coronavirus Vaccine Clinical Trial
In the last week, Moderna (NASDAQ:MRNA) substantially slowed enrollment in the phase 3 clinical trial testing its coronavirus vaccine, mRNA-1273. After a slight slowdown last week, . . .
Posted on 9/13/20
Spero Therapeutics Prices Securities Offering
CAMBRIDGE, Mass., Sept. 11, 2020 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in . . .
Posted on 9/13/20
Albireo Prices Public Offering of 4M Shares of Common Stock
BOSTON, Sept. 09, 2020 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, announced today . . .
Posted on 9/13/20
Albireo Proposes Public Offering of 3M Shares of Common Stock
BOSTON, Sept. 08, 2020 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, announced today . . .
Posted on 9/11/20
Harbour BioMed and Hualan Collaborates
Harbour BioMed (HBM), a global, clinical-stage, innovative biopharmaceutical company today announced a strategic partnership agreement with Hualan Genetic Engineering Co., Ltd to develop HBM's three proprietary innovative . . .
Posted on 9/11/20
Bruker Acquires Canopy Biosciences
BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of Canopy Biosciences, LLC, a leader in high multiplex biomarker imaging for immunology, immuno-oncology and cell . . .
Posted on 9/11/20
Vertex Pharmaceuticals Reports Positive Phase 3 Results in Children for Blockbuster CF Drug
Vertex Pharmaceuticals' (NASDAQ:VRTX) blockbuster cystic fibrosis drug Trikafta might soon have a larger addressable market. The company announced Thursday that a phase 3 trial of the . . .
Posted on 9/11/20
Why Shares of Moderna Rose While the Market Tanked on Thursday
What happenedModerna (NASDAQ:MRNA) bucked the bear market on Thursday, closing the day 1.2% higher. That lift appears to have stemmed from at-first-glance minor news about a . . .
Posted on 9/10/20
Totient Partners with Ginkgo Bioworks
Today, Ginkgo Bioworks announced a partnership with Totient, an AI-driven drug discovery company emerging from stealth, to rapidly identify neutralizing antibodies against COVID-19. Through this partnership, . . .
Posted on 9/10/20
Casma Therapeutics Completes $50M Series B Funding
Casma Therapeutics, Inc., a biotechnology company harnessing autophagy and the lysosome to design powerful new medicines, today announced the completion of a $50 million Series B . . .
Boston
